Journal profile · PHARMACOLOGY & PHARMACY
Cannabis and Cannabinoid Research
ISSN 2578-5125 · eISSN 2378-8763 · MARY ANN LIEBERT, INC · UNITED STATES
Cannabis and Cannabinoid Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.51; hybrid open access; 57 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cannabis and Cannabinoid Research is published by MARY ANN LIEBERT, INC and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cannabis and Cannabinoid Research, Neuroscience and Neuropharmacology Research and Neurotransmitter Receptor Influence on Behavior, together about 51.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Sage, a leading independent academic publisher, has acquired Mary Ann Liebert, Inc., a global media company known for publishing over 100 peer-reviewed journals in biotechnology, life sciences, clinical medicine, public health, and engineering. The journals will be available on the Sage Journals platform beginning 1 January 2026. A dual access period will run from 1 January through 30 March 2026
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cannabis and Cannabinoid ResearchMedicine41.3%
- Neuroscience and Neuropharmacology ResearchNeuroscience5.3%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience5.2%
- Forensic Toxicology and Drug AnalysisPharmacology, Toxicology and Pharmaceutics4.8%
- Substance Abuse Treatment and OutcomesMedicine4.6%
- GABA and Rice ResearchAgricultural and Biological Sciences4.4%
- Psychedelics and Drug StudiesPsychology4.4%
- Diet, Metabolism, and DiseaseMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.51LetPub ·
- CiteScore 2026-06
- 7.6LetPub ·
- SJR 2026-06
- 1.03LetPub ·
- SNIP 2026-06
- 1.05LetPub ·
- h-index
- 61OpenAlex ·
- i10-index
- 344OpenAlex ·
- 2-year mean citedness
- 3.01OpenAlex ·
- Self-citation rate
- 4%LetPub ·
- Share of gold OA articles
- 9.17%LetPub ·
Volume
- Articles per year
- 50LetPub ·
Articles by year OpenAlex count · 766 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 39 | 4 | 11 |
| 2025 | 57 | 20 | 104 |
| 2024 | 93 | 46 | 453 |
| 2023 | 117 | 45 | 1,018 |
| 2022 | 142 | 76 | 1,697 |
| 2021 | 94 | 90 | 2,128 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- MARY ANN LIEBERT, INC
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 2578-5125
- Electronic ISSN
- 2378-8763
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Cannabis and Cannabinoid Research
What CAS zone is Cannabis and Cannabinoid Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cannabis and Cannabinoid Research is in Zone 4 of Medicine, and in Zone 3 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cannabis and Cannabinoid Research?
The latest impact factor listed by LetPub is 2.51; CiteScore 7.6, h-index 61.
Which databases index Cannabis and Cannabinoid Research?
According to LetPub and DOAJ records, Cannabis and Cannabinoid Research is indexed in SCIE and Scopus.
Is Cannabis and Cannabinoid Research open access, and what is the APC?
Cannabis and Cannabinoid Research is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .